Ποια είναι η τιμή για Navamedic ASA (NAVA)

Η τιμή για Navamedic ASA (NAVA) είναι $1.58

Ποια είναι η κεφαλαιοποίηση αγοράς για Navamedic ASA (NAVA)

Η κεφαλαιοποίηση αγοράς για Navamedic ASA (NAVA) είναι $37.96M

Navamedic ASA (NAVA) Τιμή και Κεφαλαιοποίηση Αγοράς

Navamedic ASA, an Oslo, Norway-based pharmaceutical firm established in 2002 and formerly known as Glucomed AS until its name change in 2004, operates across Northern Europe. The company is actively involved in the entire lifecycle of pharmaceutical and related goods, from development and manufacturing to their commercialization and distribution. Its comprehensive portfolio encompasses a diverse range of products, including prescribed and over-the-counter medications, specialized medical nutrition, medical devices, dietary supplements, and cosmetic items. A significant portion of its offerings is dedicated to medical nutrition, formulated to address various metabolic disorders such as phenylketonuria, homocystinuria, maple syrup urine disease, tyrosinemia, methylmalonic acidemia/propionic acidemia, glutaric aciduria, isovaleric acidemia, and urea cycle disorders. These nutritional solutions also cater to conditions like glycogen storage diseases, renal diseases, fat metabolism issues, malnutrition, and support for ketogenic diets. Furthermore, Navamedic features a consumer health division providing non-prescription drugs and wellness products for common ailments including pain relief, coughs, colds, gastrointestinal issues, and women's health, primarily distributed through pharmacies and drugstores. The company also supplies specialty pharmaceuticals targeting specific therapeutic areas such as dermatology, wound care, women's health, urology, and obesity. Completing its product line are branded generics, notably in cardiology and antibiotics. Its widespread distribution network ensures products reach hospitals, individual patients, and retail pharmacies throughout its operational regions.

Η τιμή για NAVA	Το περιουσιακό στοιχείο B	Η κεφαλαιοποίηση αγοράς του B	Αποτελέσματα
$221,297 $37.96M	NVDA	$5.307T	+13,982,051.09%
$195,878 $37.96M	AAPL	$4.697T	+12,375,980.66%
$172,919 $37.96M	GOOG	$4.147T	+10,925,385.43%
$149,434 $37.96M	MSFT	$3.584T	+9,441,565.92%
$118,193 $37.96M	AMZN	$2.834T	+7,467,675.80%

Η τιμή για NAVA

Το περιουσιακό στοιχείο B

Η κεφαλαιοποίηση αγοράς του B

Αποτελέσματα

$221,297 $37.96M